Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01437566
Title Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | NZL | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Additional content available in CKB BOOST